182 related articles for article (PubMed ID: 32816913)
1. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer.
Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K
Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913
[TBL] [Abstract][Full Text] [Related]
2. The Induction of Selected Wnt Target Genes by Tcf1 Mediates Generation of Tumorigenic Colon Stem Cells.
Shiokawa D; Sato A; Ohata H; Mutoh M; Sekine S; Kato M; Shibata T; Nakagama H; Okamoto K
Cell Rep; 2017 May; 19(5):981-994. PubMed ID: 28467911
[TBL] [Abstract][Full Text] [Related]
3. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
[TBL] [Abstract][Full Text] [Related]
5. PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells.
Ragusa S; Cheng J; Ivanov KI; Zangger N; Ceteci F; Bernier-Latmani J; Milatos S; Joseph JM; Tercier S; Bouzourene H; Bosman FT; Letovanec I; Marra G; Gonzalez M; Cammareri P; Sansom OJ; Delorenzi M; Petrova TV
Cell Rep; 2014 Sep; 8(6):1957-1973. PubMed ID: 25242332
[TBL] [Abstract][Full Text] [Related]
6. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin-Fc chimera protein matrix enhances cancer stem-like properties and induces mesenchymal features in colon cancer cells.
Qian Y; Wu X; Yokoyama Y; Okuzaki D; Taguchi M; Hirose H; Wang J; Hata T; Inoue A; Hiraki M; Ohtsuka M; Takahashi H; Haraguchi N; Mizushima T; Tanaka S; Mori M; Yamamoto H
Cancer Sci; 2019 Nov; 110(11):3520-3532. PubMed ID: 31505062
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
Högström J; Heino S; Kallio P; Lähde M; Leppänen VM; Balboa D; Wiener Z; Alitalo K
Cancer Res; 2018 Oct; 78(20):5820-5832. PubMed ID: 30154153
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
10. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
12. Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.
Jian Y; Wang M; Zhang Y; Ou R; Zhu Z; Ou Y; Chen X; Liang X; Ding Y; Song L; Xu X; Liao W
Cancer Lett; 2018 Aug; 428():1-11. PubMed ID: 29660380
[TBL] [Abstract][Full Text] [Related]
13. Visualization and targeting of LGR5
Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
[TBL] [Abstract][Full Text] [Related]
14. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
15. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
Gao S; Soares F; Wang S; Wong CC; Chen H; Yang Z; Liu W; Go MYY; Ahmed M; Zeng Y; O'Brien CA; Sung JJY; He HH; Yu J
Oncogene; 2021 Dec; 40(48):6601-6613. PubMed ID: 34621019
[TBL] [Abstract][Full Text] [Related]
16. Differential localization of LGR5 and Nanog in clusters of colon cancer stem cells.
Amsterdam A; Raanan C; Schreiber L; Freyhan O; Fabrikant Y; Melzer E; Givol D
Acta Histochem; 2013 May; 115(4):320-9. PubMed ID: 23098761
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
Petrova TV; Nykänen A; Norrmén C; Ivanov KI; Andersson LC; Haglund C; Puolakkainen P; Wempe F; von Melchner H; Gradwohl G; Vanharanta S; Aaltonen LA; Saharinen J; Gentile M; Clarke A; Taipale J; Oliver G; Alitalo K
Cancer Cell; 2008 May; 13(5):407-19. PubMed ID: 18455124
[TBL] [Abstract][Full Text] [Related]
18. PROX1 induction by autolysosomal activity stabilizes persister-like state of colon cancer via feedback repression of the NOX1-mTORC1 pathway.
Ohata H; Shiokawa D; Sakai H; Kanda Y; Okimoto Y; Kaneko S; Hamamoto R; Nakagama H; Okamoto K
Cell Rep; 2023 Jun; 42(6):112519. PubMed ID: 37224811
[TBL] [Abstract][Full Text] [Related]
19. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
Kumar S; Raina K; Agarwal C; Agarwal R
Oncotarget; 2014 Jul; 5(13):4972-89. PubMed ID: 24970802
[TBL] [Abstract][Full Text] [Related]
20. Rapidly cycling Lgr5
Kim E; Davidson LA; Zoh RS; Hensel ME; Salinas ML; Patil BS; Jayaprakasha GK; Callaway ES; Allred CD; Turner ND; Weeks BR; Chapkin RS
Cell Death Dis; 2016 Nov; 7(11):e2460. PubMed ID: 27831561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
